
PharmaSGP Holding SE
PSG | F
Overview
Corporate Details
- ISIN(s):
- DE000A2P4LJ5
- LEI:
- 3912005CZ12PVVCIPT91
- Country:
- Germany
- Address:
- Lochhamer Schlag 1, 82166 Gräfelfing
- Website:
- https://pharmasgp.com/english/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products. Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers. In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany. Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-11 11:15 |
Directors' Dealings
PharmaSGP Holding SE: FUTRUE GmbH, Interest-sustaining purchase order for up to…
|
English | 6.6 KB | |
2025-06-10 08:42 |
Delisting Announcement
PharmaSGP Holding SE: Conclusion of a delisting agreement and announcement of a…
|
English | 13.5 KB | |
2025-05-28 00:00 |
Regulatory News Service
Q1 statement / Q1 financial report 2025
|
English | 517.8 KB | |
2025-05-19 15:01 |
Directors' Dealings
PharmaSGP Holding SE: FUTRUE GmbH, buy
|
English | 6.0 KB | |
2025-05-16 07:30 |
Regulatory News Service
PharmaSGP continues its growth course in 2025
|
English | 15.9 KB | |
2025-05-14 15:05 |
Regulatory News Service
PharmaSGP Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 25…
|
German | 127.8 KB | |
2025-05-09 11:00 |
Regulatory News Service
|
English | 12.1 KB | |
2025-04-30 00:00 |
Takeover Announcement Report
Annual financial report 2024
|
English | 22.7 MB | |
2025-04-23 14:30 |
Regulatory News Service
|
English | 4.4 KB | |
2025-04-15 07:30 |
Regulatory News Service
PharmaSGP with significant increase in revenues and EBITDA in 2024
|
English | 16.7 KB | |
2024-11-29 00:00 |
Quarterly Report
Q3 statement / Q3 financial report 2024
|
English | 517.2 KB | |
2024-11-28 00:00 |
Quarterly Report
Q3 statement / Q3 financial report 2024
|
English | 517.2 KB | |
2024-11-28 00:00 |
Quarterly Report
Q3 statement / Q3 financial report 2024
|
English | 517.2 KB | |
2024-11-25 12:00 |
Directors' Dealings
PharmaSGP Holding SE: FUTRUE GmbH, buy
|
English | 7.8 KB | |
2024-11-05 10:07 |
Board/Management Change
CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as …
|
English | 9.2 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2024-11-25 | FUTRUE GmbH | Close relation | Buy | None | 12,145,250.00 EUR |
2022-10-05 | MMI Leisure & Capital Management GmbH | Close relation | Buy | None | 125,383.20 EUR |
2022-10-05 | Hillen, Ingo | Board | Buy | None | 1,048.00 EUR |
2022-10-05 | MMI Leisure & Capital Management GmbH | Close relation | Buy | None | 26.60 EUR |
2022-05-30 | Wittig, Dr. Thomas | Supervisory board | Buy | None | 138,953.80 EUR |
2022-05-30 | Schröter, Jasmin | Close relation | Buy | None | 119,660.00 EUR |
2022-05-30 | Simon-Schröter, Dr. Wolfram | Other | Buy | None | 10,040.00 EUR |
2022-04-25 | FUTRUE GmbH | Close relation | Buy | None | 208,180.53 EUR |
2022-04-25 | MMI Leisure & Capital Management GmbH | Close relation | Sell | None | 197,193.60 EUR |
2022-04-25 | Bloching, Prof. Dr. Micha | Supervisory board | Sell | None | 171,825.00 EUR |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Antibiotice S.A. | Romania | ATB | |
![]() |
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
![]() |
Asarina Pharma AB | Sweden | ASAP |